Estradiol/nomegestrol intravaginal ring
Alternative Names: MK-8175A intravaginal; NOMAC-CVR; NOMAC/CVR; Nomegestrol acetate contraceptive vaginal ring; Nomegestrol/estradiol intravaginal ring; SCH-900121 intravaginalLatest Information Update: 24 Oct 2021
At a glance
- Originator Merck & Co
- Class Estradiol congeners; Estrenes; Hormonal contraceptives; Hormonal replacements; Pregnadienes; Progesterone congeners; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Dysmenorrhoea; Pregnancy
Most Recent Events
- 21 Aug 2015 No recent reports of development identified - Phase-II for Dysmenorrhoea in Norway, Germany, Sweden, Denmark, Spain, Poland and Netherlands (Vaginal)
- 21 Aug 2015 No recent reports of development identified - Phase-II for Pregnancy (Prevention) in Sweden, Spain, Poland, Norway, Netherlands, Hungary, Denmark, Denmark, Germany and USA (Vaginal)
- 01 Oct 2013 Merck completes a phase II trial in Contraception/Pregnancy (Prevention) in Denmark, Germany, Hungary, the Netherlands, Norway, Poland, Spain, Sweden, and in the US (NCT01709318)